和仁科技(300550.SZ)：2025年中报净利润为-352.00万元

Core Insights - The company reported a total revenue of 159 million yuan for the first half of 2025, a decrease of 1.58 million yuan compared to the same period last year, representing a year-on-year decline of 0.99% [1] - The net profit attributable to shareholders was -3.52 million yuan, indicating a loss [1] - The net cash inflow from operating activities was -64.99 million yuan [1] Financial Metrics - The latest debt-to-asset ratio is 22.87%, an increase of 1.42 percentage points from the previous quarter [3] - The latest gross profit margin stands at 43.41% [3] - The return on equity (ROE) is -0.32% [3] - The diluted earnings per share (EPS) is -0.01 yuan [3] - The total asset turnover ratio remained flat compared to the same period last year, with a year-on-year decline of 2.14% [3] - The latest inventory turnover ratio is 4.45 times [3] Shareholder Structure - The number of shareholders is 10,200, with the top ten shareholders holding 155 million shares, accounting for 59.06% of the total share capital [3] - The largest shareholder is Tongce Medical Co., Ltd., holding 19.01% [3] - Other significant shareholders include Hangzhou Panyuan Investment Co., Ltd. at 15.33% and Xiamen Silicon Valley Shaohua No.1 Investment Partnership at 10.01% [3]